Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease

Neuroscience Letters

Volumn 261, Issue 1-2, 1999, Pages 124-126

  Kropp, Stefan ^a   Zerr, Inga ^a   Schulz Schaeffer, Walter J ^a   Riedemann, Christian ^a   Bodemer, Monika ^a   Laske, Christof ^a   Kretzschmar, Hans A ^a   Poser, Sigrid ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cerebrospinal fluid; Creutzfeldt Jakob disease; Disease progression; Neuron specific enolase

Indexed keywords

NEURON SPECIFIC ENOLASE;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL LOSS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; NERVE DEGENERATION; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

14-3-3 PROTEINS; ADULT; AGED; CREUTZFELDT-JAKOB SYNDROME; DISEASE PROGRESSION; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PROTEINS; TAU PROTEINS; TYROSINE 3-MONOOXYGENASE;

EID: 0033548032     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00992-6     Document Type: Article

References (14)

1. Creutzfeldt H.G. Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems (vorläufige Mitteilung). Z. Ges. Neurol. Psychiatr. 57:1920;1-18.
2. Evers S., Droste D.W., Lüdemann P., Oberwittler C. Early elevation of cerebrospinal fluid neuron-specific enolase in Creutzfeldt-Jakob disease. J. Neurol. 145:1998;52-53.
3. Fizazi K., Cojean I., Pignon J.P., Rixe O., Gatineau M., Hadef S., Arriagada R., Baldeyrou P., Comoy E., Le Chevalier T. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma. Cancer. 82:1998;1049-1055.
4. Hsich G., Kenney K., Gibbs C.J., Lee K.H., Harrington M.G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335:1996;924-930.
5. Jakob A. Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswerten anatomischen Befunden (Spastische Pseudosklerose-Encephalomyopathie mit disseminierten Degenerationsherden). Z. Ges. Neurol. Psychiatr. 64:1921;147-228.
6. Jimi T., Wakayama Y., Shibuya S., Nakata H., Tomaru T., Takahashi Y., Kosaka K., Asano T., Kato K. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease. Clin. Chim. Acta. 211:1992;37-46.
7. Kretzschmar H.A., Ironside J.W., DeArmond S.J., Tateishi J. Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease. Arch. Neurol. 53:1996;913-920.
8. Otto M., Wiltfang J., Tumani H., Zerr I., Lantsch M., Kornhuber J., Weber T., Kretzschmar H.A., Poser S. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci. Lett. 225:1997;210-212.
9. Otto M., Wiltfang J., Schütz E., Zerr I., Otto A., Pfahlberg A., Gefeller O., Uhr M., Giese A., Weber T., Kretzschmar H.A., Poser S. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. Br. Med. J. 316:1998;577-582.
10. Otto M., Beekes M., Bahn E., Poser S., Diringer H. Elevated levels of serum S100 beta protein in scrapie hamsters. J. Neurovirol. 4:1998;572-573.
11. Prange H.W., Aue G., Frauendorf H., Reiber H. Die neuronenspezifische Enolase als Prognosemarker bei zerebraler Hypoxie. Intensivmed. 32:1994;17-22.
12. Schaarschmidt H., Prange H.W., Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular disease. Stroke. 25:1994;558-565.
13. Zerr I., Bodemer M., Gefeller O., Otto M., Poser S., Wiltfang J., Windl O., Kretzschmar H.A., Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann. Neurol. 43:1998;32-40.
14. Zerr I., Bodemer M., Räcker S., Grosche S., Poser S., Kretzschmar H.A., Weber T. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet. 345:1995;1609-1610.